https://destinypharma.com/ 2025-11-10T12:42:25+00:00 https://destinypharma.com/investors/matched-bargain-facility/ 2024-08-16T10:47:47+00:00 https://destinypharma.com/archived-reports-and-presentations/ 2023-04-14T15:01:43+00:00 https://destinypharma.com/about-us/board-committees/ 2023-09-21T13:28:36+00:00 https://destinypharma.com/capital-structure/ 2024-01-10T19:14:33+00:00 https://destinypharma.com/investors/email-alerts/ 2024-08-16T12:59:57+00:00 https://destinypharma.com/investors/advisers-shareholder-contacts/ 2024-08-13T06:10:44+00:00 https://destinypharma.com/investors/reports-and-presentations/ 2024-07-31T10:15:11+00:00 https://destinypharma.com/investors/constitutional-documents/ 2024-09-06T13:42:32+00:00 https://destinypharma.com/investors/press-releases/ 2024-08-13T06:07:09+00:00 https://destinypharma.com/terms-of-use/ 2024-09-06T12:09:05+00:00 https://destinypharma.com/about-us/our-values/ 2023-03-28T11:28:23+00:00 https://destinypharma.com/pipeline/ 2025-11-10T12:43:25+00:00 https://destinypharma.com/contact/ 2022-11-11T11:38:52+00:00 https://destinypharma.com/careers/ 2023-12-13T14:08:06+00:00 https://destinypharma.com/investors/ 2022-10-25T09:30:56+00:00 https://destinypharma.com/news/latest/ 2022-12-13T11:23:55+00:00 https://destinypharma.com/news/ 2024-01-18T15:07:54+00:00 https://destinypharma.com/partnering/ 2025-11-10T12:44:43+00:00 https://destinypharma.com/our-technologies/biotherapeutics/ntcd-m3/ 2023-05-12T11:39:58+00:00 https://destinypharma.com/our-technologies/xf-platform/ 2023-07-13T13:00:56+00:00 https://destinypharma.com/our-technologies/biotherapeutics/ 2024-05-02T15:04:19+00:00 https://destinypharma.com/our-technologies/ 2022-10-25T09:30:56+00:00 https://destinypharma.com/target-markets/anti-microbial-resistance/ 2023-07-13T13:03:00+00:00 https://destinypharma.com/target-markets/post-surgical-infections/ 2023-07-13T12:59:30+00:00 https://destinypharma.com/target-markets/clostridioides-difficile-infections/ 2025-11-10T12:48:00+00:00 https://destinypharma.com/about-us/ 2024-05-02T14:53:47+00:00 https://destinypharma.com/target-markets/ 2023-03-28T12:07:46+00:00 https://destinypharma.com/privacy-policy/ 2024-09-06T12:03:41+00:00 https://destinypharma.com/2024/08/28/fda-grants-xf-73-dermal-qipd-for-burn-wound-infections/ 2025-11-10T12:59:04+00:00 https://destinypharma.com/2024/08/22/decision-of-the-board-of-directors-to-appoint-administrators/ 2025-11-10T12:59:11+00:00 https://destinypharma.com/news-and-media/events/escmid-asm/ 2024-08-20T06:38:37+00:00 https://destinypharma.com/2024/08/20/destiny-pharma-to-deliver-presentation-at-the-european-society-of-clinical-microbiology-and-infectious-disease-conference/ 2025-11-10T12:58:51+00:00 https://destinypharma.com/2024/08/14/destiny-pharma-initiates-research-to-explore-xf-drug-potential-for-cf/ 2025-11-10T12:58:57+00:00 https://destinypharma.com/2024/08/13/destiny-pharma-shares-now-trading-on-jp-jenkins/ 2025-11-10T12:51:17+00:00 https://destinypharma.com/2024/08/12/last-day-of-dealings-on-aim/ 2025-11-10T12:58:44+00:00 https://destinypharma.com/2024/08/05/xf-73-prevents-bacterial-invasion-of-bloodstream/ 2025-11-17T13:00:44+00:00 https://destinypharma.com/2024/07/31/result-of-gm-and-cancellation-of-trading-on-aim/ 2025-11-17T13:00:33+00:00 https://destinypharma.com/2024/07/22/treatment-of-xf-73-nasal-reduces-antibiotic-use/ 2025-11-17T13:00:20+00:00 https://destinypharma.com/2024/07/17/destiny-pharma-plc-aim-delisting-frequently-asked-questions/ 2024-07-17T12:43:13+00:00 https://destinypharma.com/2024/07/15/proposed-cancellation-of-admission-to-trading/ 2025-11-17T13:00:08+00:00 https://destinypharma.com/2024/06/18/efficacy-of-xf-70-in-fungal-skin-infections/ 2025-11-17T12:58:40+00:00 https://destinypharma.com/2024/06/12/result-of-2024-annual-general-meeting/ 2025-11-17T12:58:06+00:00 https://destinypharma.com/2024/06/11/destiny-pharmas-xf-73-nasal-awarded-mhra-ilap/ 2025-11-10T12:52:33+00:00 https://destinypharma.com/2024/05/10/uk-5-year-action-plan-for-antimicrobial-resistance-2024-to-2029/ 2024-05-14T10:24:28+00:00 https://destinypharma.com/2024/05/09/posting-of-annual-report-and-notice-of-agm/ 2025-11-10T12:52:51+00:00 https://destinypharma.com/2024/04/25/audited-results-for-the-year-ended-31-december-2023-and-review-of-strategic-options/ 2025-11-10T12:53:12+00:00 https://destinypharma.com/2024/04/08/notice-of-full-year-results-and-investor-presentation/ 2025-11-10T12:54:05+00:00 https://destinypharma.com/news-and-media/media-coverage/destiny-pharmas-chairman-sir-nigel-rudd-receives-lifetime-achievement-award-at-the-annual-ned-awards/ 2024-03-27T11:48:41+00:00 https://destinypharma.com/news-and-media/media-coverage/destiny-pharma-featured-in-daily-mail/ 2024-03-11T18:44:53+00:00 https://destinypharma.com/2024/01/31/clinical-development-update/ 2024-01-31T09:43:03+00:00 https://destinypharma.com/news-and-media/events/bio-europe-spring/ 2024-01-25T14:47:45+00:00 https://destinypharma.com/news-and-media/events/biotech-showcase/ 2024-01-23T13:46:29+00:00 https://destinypharma.com/2024/01/22/5749/ 2025-11-10T13:01:00+00:00 https://destinypharma.com/2024/01/04/year-end-business-update/ 2024-01-04T07:14:40+00:00 https://destinypharma.com/news-and-media/events/bos-manchester-2023/ 2023-11-20T13:27:58+00:00 https://destinypharma.com/news-and-media/events/emerging-antimicrobials-and-diagnostics-in-amr-2023/ 2023-11-14T18:49:15+00:00 https://destinypharma.com/news-and-media/events/jefferies-london-healthcare-conference/ 2023-11-09T14:04:38+00:00 https://destinypharma.com/news-and-media/media-coverage/destiny-pharma-featured-in-the-mail-on-sunday-29th-october-2023/ 2023-11-02T11:49:06+00:00 https://destinypharma.com/news-and-media/events/bio-europe-2023/ 2023-10-31T11:32:00+00:00 https://destinypharma.com/2023/10/17/5693/ 2023-10-17T09:16:49+00:00 https://destinypharma.com/2023/10/17/publication-of-new-microbiological-data-for-xf-73/ 2023-10-17T13:10:54+00:00 https://destinypharma.com/2023/09/27/notice-of-xf-pipeline-update-meeting/ 2023-09-27T06:22:10+00:00 https://destinypharma.com/2023/09/20/interim-results-for-the-six-months-ended-30-june-2023/ 2023-09-20T06:25:11+00:00 https://destinypharma.com/2023/07/31/publication-of-new-data-for-xf-73/ 2023-07-31T11:16:21+00:00 https://destinypharma.com/2023/07/25/appointment-of-new-chairman/ 2023-07-25T08:45:24+00:00 https://destinypharma.com/2023/07/19/board-changes-including-appointment-of-new-ceo/ 2023-07-19T12:13:18+00:00 https://destinypharma.com/2023/07/06/positive-findings-from-recent-sab-meeting/ 2023-07-06T06:45:21+00:00 https://destinypharma.com/2023/06/29/business-update/ 2023-06-29T08:26:26+00:00 https://destinypharma.com/2023/05/25/result-of-2023-annual-general-meeting/ 2023-05-25T11:46:56+00:00 https://destinypharma.com/2023/05/25/dr-debra-barker-appointed-interim-ceo/ 2023-05-25T09:12:16+00:00 https://destinypharma.com/news-and-media/events/bos-basel-2023/ 2023-05-24T11:30:44+00:00 https://destinypharma.com/news-and-media/events/microbiome-connect-europe-2023/ 2023-05-24T11:22:33+00:00 https://destinypharma.com/news-and-media/events/bio-international-convention/ 2023-05-12T14:17:01+00:00 https://destinypharma.com/news-and-media/events/lsx-world-congress-2023/ 2023-05-02T15:47:59+00:00 https://destinypharma.com/news-and-media/events/bioequity-europe-2023/ 2023-05-02T15:26:20+00:00 https://destinypharma.com/2023/05/02/positive-results-from-spor-cov-research/ 2023-05-02T06:06:50+00:00 https://destinypharma.com/2023/04/26/posting-of-annual-report-and-accounts-and-notice-of-agm/ 2023-04-28T09:36:32+00:00 https://destinypharma.com/2023/04/13/audited-results-for-year-ended-31-december-2022/ 2023-04-20T14:57:49+00:00 https://destinypharma.com/news-and-media/media-coverage/neil-clark-of-destiny-pharma-our-number-one-target-is-a-deal-on-xf-73-this-year-vox-markets/ 2023-04-14T11:11:31+00:00 https://destinypharma.com/news-and-media/media-coverage/destiny-pharma-cso-discusses-breakthrough-treatment-for-c-difficile-infection/ 2023-04-20T15:39:02+00:00 https://destinypharma.com/2023/04/03/notice-of-results-and-investor-presentation/ 2023-04-14T11:14:58+00:00 https://destinypharma.com/news-and-media/media-coverage/neil-clark-of-destiny-pharma-discusses-xf-73s-significant-phase-2-data-published-in-a-peer-reviewed-journal-potential-upside-vox-markets/ 2023-04-14T11:09:31+00:00 https://destinypharma.com/2023/03/24/landmark-xf-73-phase-2-data-published-in-us-journal/ 2024-08-09T12:02:32+00:00 https://destinypharma.com/news-and-media/events/proactive-one2one-investor-forum/ 2023-04-14T11:03:59+00:00 https://destinypharma.com/news-and-media/events/7th-annual-microbiome-movement-drug-development-europe-31-january-2-february-2023/ 2023-03-16T15:47:29+00:00 https://destinypharma.com/news-and-media/events/eccmid-15-18-april-2023/ 2023-03-16T15:44:53+00:00 https://destinypharma.com/2023/03/16/issue-of-equity/ 2023-03-16T15:44:15+00:00 https://destinypharma.com/2023/03/16/neil-clark-speaks-to-endpoint-uk-biotech-hands-off-mid-stage-c-difficile-drug-in-up-to-570m-deal/ 2023-03-16T15:45:05+00:00 https://destinypharma.com/2023/03/16/circular-to-shareholders-4/ 2023-04-14T10:48:13+00:00 https://destinypharma.com/2023/03/16/open-offer-application-form/ 2023-04-14T10:50:11+00:00 https://destinypharma.com/2023/03/16/form-of-proxy-2/ 2023-04-14T10:49:26+00:00 https://destinypharma.com/2023/03/16/result-of-general-meeting-and-total-voting-rights-2/ 2023-04-14T10:51:57+00:00 https://destinypharma.com/2023/03/15/result-of-open-offer/ 2025-11-17T13:09:23+00:00 https://destinypharma.com/news-and-media/media-coverage/neil-clark-updates-proactive-investors-on-progress/ 2023-04-20T14:44:03+00:00 https://destinypharma.com/news-and-media/media-coverage/neil-clark-shaun-claydon-of-destiny-pharma-collaboration-for-ntcd-m3-worth-up-to-570m-plus-royalties-vox-markets/ 2023-04-20T14:44:53+00:00 https://destinypharma.com/2023/01/25/25-january-2023-us-center-for-disease-control-review-paper/ 2025-11-17T13:08:26+00:00 https://destinypharma.com/2022/12/22/22-december-2022-year-end-trading-update/ 2025-11-17T13:06:05+00:00 https://destinypharma.com/2022/12/07/xf-73-nasal-final-phase-3-development-plans/ 2025-11-17T13:07:50+00:00 https://destinypharma.com/news-and-media/media-coverage/neil-clark-speaks-to-labiotech-about-antimicrobial-resistance/ 2023-04-20T14:45:35+00:00 https://destinypharma.com/2022/11/21/21-november-2022-destiny-pharmas-amr-paper/ 2022-12-13T13:32:38+00:00 https://destinypharma.com/news-and-media/media-coverage/bill-love-speaks-to-proactive-investors-on-addressing-the-global-threat-of-superbugs-and-amr/ 2023-04-20T14:46:15+00:00 https://destinypharma.com/2022/11/18/18-november-2022-dr-bill-love-speaks-to-proactive-investors-about-how-destiny-pharma-is-addressing-the-global-threat-of-superbugs-and-amr/ 2022-12-13T13:32:44+00:00 https://destinypharma.com/2022/11/15/15-november-2022-xf-73-dermal-infection-project-advances-into-clinically-enabling-safety-study-with-us-governments-niaid/ 2025-11-17T13:07:25+00:00 https://destinypharma.com/news-and-media/events/invetival-showcase-14-november-2022/ 2022-12-01T12:16:56+00:00 https://destinypharma.com/news-and-media/events/jefferies-london-healthcare-conference-15-17-november-2022/ 2022-12-01T12:17:48+00:00 https://destinypharma.com/2022/10/19/19-october-2022-destiny-pharma-rd-investor-update-meeting-presentation-recording/ 2023-03-14T19:30:53+00:00 https://destinypharma.com/pipeline/xf-73-dermal/ 2023-03-28T12:06:28+00:00 https://destinypharma.com/pipeline/xf-73-nasal/ 2023-05-19T08:45:34+00:00 https://destinypharma.com/pipeline/xf-73-drugs-research/ 2023-04-16T10:25:38+00:00 https://destinypharma.com/news-and-media/events/microbiome-connect-usa-16-17-november-2022/ 2022-12-01T12:18:22+00:00 https://destinypharma.com/news-and-media/events/bio-europe-2022-24-26-october-2022/ 2022-12-01T12:18:43+00:00 https://destinypharma.com/news-and-media/media-coverage/neil-clark-speaks-to-stockbox-media-on-ntcd-m3/ 2023-04-20T14:46:56+00:00 https://destinypharma.com/2022/09/22/22-september-2022-notice-of-rd-update-meeting/ 2025-11-17T13:06:53+00:00 https://destinypharma.com/2022/09/09/exercise-of-options-and-total-voting-rights/ 2023-03-15T09:45:44+00:00 https://destinypharma.com/news-and-media/media-coverage/neil-clark-shaun-claydon-of-destiny-pharma-significant-progress-in-h1-will-continue-in-2022-beyond-vox-markets/ 2022-11-10T12:18:14+00:00 https://destinypharma.com/2022/09/08/interim-results-for-six-months-ended-30-june-2022/ 2022-09-08T13:37:00+00:00 https://destinypharma.com/2022/09/08/08-september-2022-interim-results-for-six-months-ended-30-june-2022/ 2023-03-16T11:07:20+00:00 https://destinypharma.com/2022/09/07/destiny-pharma-ceo-neil-clark-to-present-at-the-hc-wainwright-24th-annual-global-investment-conference/ 2022-09-07T13:34:21+00:00 https://destinypharma.com/2022/09/07/07-september-2022-destiny-pharma-ceo-neil-clark-to-present-at-the-hc-wainwright-24th-annual-global-investment-conference/ 2025-11-17T13:06:31+00:00 https://destinypharma.com/2022/08/26/notice-of-interim-results-and-investor-presentation/ 2023-03-20T09:46:15+00:00 https://destinypharma.com/news-and-media/events/hc-wainwright-24th-annual-global-investment-conference-12-14-september-2022/ 2022-12-01T12:19:22+00:00 https://destinypharma.com/2022/08/22/22-august-2022-notice-of-interim-results-and-investor-presentation/ 2023-03-16T11:07:20+00:00 https://destinypharma.com/news-and-media/events/7th-microbiome-movement-drug-development-2022-21-24-june-2022/ 2022-12-01T12:20:32+00:00 https://destinypharma.com/news-and-media/events/anaerobe-2022-28-31-july/ 2022-12-01T12:20:48+00:00 https://destinypharma.com/2022/07/28/chairs-investor-update/ 2022-07-28T09:18:45+00:00 https://destinypharma.com/2022/07/28/28-july-2022-chairs-investor-update/ 2023-03-16T11:07:20+00:00 https://destinypharma.com/news-and-media/media-coverage/destiny-pharma-discusses-positive-update-from-fda-on-their-xf-73-nasal-gel/ 2022-11-10T12:18:06+00:00 https://destinypharma.com/news-and-media/media-coverage/destiny-pharma-to-trial-nasal-gel-in-breast-surgery-after-positive-fda-feedback/ 2022-11-10T11:58:42+00:00 https://destinypharma.com/2022/07/19/19-july-2022-positive-update-from-us-fda-on-xf-73-phase-3/ 2023-03-16T11:07:20+00:00 https://destinypharma.com/news-and-media/events/id-week-19-23-october-2022/ 2022-12-01T12:21:08+00:00 https://destinypharma.com/2022/07/12/12-july-2022-destiny-pharma-receives-award-from-the-cystic-fibrosis-foundation/ 2023-03-20T09:53:56+00:00 https://destinypharma.com/2022/07/07/07-july-2022-destiny-pharma-announce-publication-of-xf-73-drug-synergy-data/ 2023-03-16T11:07:20+00:00 https://destinypharma.com/2022/07/05/05-july-2022-destiny-pharma-announces-start-of-a-new-xf-73-research-programme/ 2023-03-16T11:07:20+00:00 https://destinypharma.com/news-and-media/events/8th-annual-microbiome-connect-europe-2022-6-7-july-2022/ 2022-06-07T15:19:44+00:00 https://destinypharma.com/news-and-media/events/7th-microbiome-movement-drug-development-21-24-june-2022/ 2022-06-07T15:18:53+00:00 https://destinypharma.com/2022/05/27/27-may-2022-result-of-annual-general-meeting-and-strategy-update/ 2023-03-16T11:07:20+00:00 https://destinypharma.com/2022/05/26/26-may-2022-destiny-pharma-plc-board-changes/ 2023-03-16T11:07:20+00:00 https://destinypharma.com/news-and-media/events/bio-international-convention-13-16-june-2022/ 2022-05-23T12:20:46+00:00 https://destinypharma.com/news-and-media/media-coverage/destiny-pharma-highlights-new-landmark-ntcd-m3-data/ 2023-04-20T14:54:30+00:00 https://destinypharma.com/news-and-media/media-coverage/destiny-pharma-plc-on-its-two-lead-infection-prevention-assets/ 2022-11-10T12:01:43+00:00 https://destinypharma.com/news-and-media/events/bioequity-europe-16-18-may-2022/ 2022-05-04T12:46:36+00:00 https://destinypharma.com/news-and-media/events/lsx-world-congress-2022-10-11-may-2022/ 2022-05-04T11:53:42+00:00 https://destinypharma.com/2022/05/04/04-may-2022-destinys-chief-business-officer-dr-stephanie-bewick-speaks-to-labiotech-about-her-role/ 2023-03-16T11:07:20+00:00 https://destinypharma.com/2022/05/03/03-may-2022-destiny-pharma-appoints-dr-yuri-martina-as-chief-medical-officer/ 2023-03-16T11:07:20+00:00 https://destinypharma.com/2022/04/27/27-april-2022-posting-of-annual-report-and-notice-of-agm/ 2023-03-16T11:07:20+00:00 https://destinypharma.com/news-and-media/events/world-of-microbiome-28-30-april-2022/ 2022-04-21T10:13:50+00:00 https://destinypharma.com/news-and-media/events/infection-prevention-and-control-26-27-april-2022/ 2022-04-21T10:10:45+00:00 https://destinypharma.com/news-and-media/media-coverage/destiny-pharma-discusses-2021-highlights-and-what-is-expected-in-2022/ 2023-04-20T15:46:08+00:00 https://destinypharma.com/2022/04/12/12-april-2022-audited-results-for-year-ended-31-december-2021/ 2023-03-16T11:07:20+00:00 https://destinypharma.com/2022/03/31/31-march-2022-presenting-data-at-the-eccmid-2022-congress/ 2023-03-20T10:00:56+00:00 https://destinypharma.com/2022/03/28/result-of-general-meeting-and-total-voting-rights/ 2023-03-20T10:03:53+00:00 https://destinypharma.com/2022/03/25/destinys-microbiome-project-article-published-in-vantage/ 2022-03-25T13:49:39+00:00 https://destinypharma.com/2022/03/25/result-of-open-offer-2/ 2023-03-20T10:05:12+00:00 https://destinypharma.com/2022/03/23/destiny-pharma-publish-in-the-european-biopharmaceutical-review-journal-global-rise-in-amr-threatens-infection-armageddon/ 2023-03-20T10:06:58+00:00 https://destinypharma.com/2022/03/22/exercise-of-options-and-total-voting-rights-2/ 2023-03-20T10:07:43+00:00 https://destinypharma.com/news-and-media/events/eccmid-2022-23-26-april-2022/ 2022-03-21T11:51:53+00:00 https://destinypharma.com/news-and-media/media-coverage/destiny-pharma-presentation-at-the-proactive-one2one-virtual-forum/ 2023-04-20T15:46:17+00:00 https://destinypharma.com/2022/03/17/open-offer-application-form-3/ 2023-03-14T19:15:43+00:00 https://destinypharma.com/2022/03/17/form-of-proxy/ 2023-03-20T10:09:32+00:00 https://destinypharma.com/2022/03/09/circular-to-shareholders/ 2023-03-20T10:10:42+00:00 https://destinypharma.com/news-and-media/media-coverage/destiny-pharma-podcast-presentation-to-vox-markets-new-funds-will-progress-two-lead-clinical-assets-towards-phase-3-trials/ 2023-04-20T15:46:25+00:00 https://destinypharma.com/2022/03/08/08-march-2022-fundraising/ 2023-03-20T10:11:34+00:00 https://destinypharma.com/2022/02/08/08-february-2022-positive-feedback-from-ema-on-xf-73-nasal-gel-phase-3-programme/ 2023-03-20T10:12:14+00:00 https://destinypharma.com/news-and-media/media-coverage/destiny-pharma-prepares-to-move-to-final-study-on-novel-xf-73-dermal-formulation/ 2023-04-20T15:46:33+00:00 https://destinypharma.com/2022/02/01/01-february-2022-positive-data-in-xf-73-dermal-study-with-niaid/ 2023-03-20T10:13:01+00:00 https://destinypharma.com/news-and-media/events/bio-europe-spring-28-31-march-2022/ 2022-01-25T10:45:42+00:00 https://destinypharma.com/2022/01/21/21-january-2022-destiny-pharma-lancet-report/ 2023-03-20T10:16:22+00:00 https://destinypharma.com/2022/01/17/17-jan-2022-strategy-company-ops-update/ 2023-03-20T10:19:39+00:00 https://destinypharma.com/news-and-media/events/hc-wainwright-bioconnect-conference-10-13-january-2022/ 2022-01-05T12:07:55+00:00 https://destinypharma.com/2021/12/16/16-december-2021-destiny-pharma-presents-at-the-3rd-annual-bio-cross-border-investment-partnership-event/ 2023-03-20T10:20:11+00:00 https://destinypharma.com/news-and-media/events/biotech-showcase-2022-10-12-january-2022/ 2021-12-16T10:27:45+00:00 https://destinypharma.com/news-and-media/events/3rd-annual-bio-cross-border-investment-partnership-summit-16-december-2021/ 2021-12-16T09:15:42+00:00 https://destinypharma.com/news-and-media/media-coverage/destiny-pharma-2021-and-beyond-presentation-to-vox-markets/ 2023-04-20T15:46:41+00:00 https://destinypharma.com/news-and-media/media-coverage/destiny-pharma-presentation-at-the-proactive-one2one-investor-forum/ 2023-04-20T15:46:51+00:00 https://destinypharma.com/news-and-media/events/microbiome-connect-gut-therapeutics-europe-7-9-december-2021/ 2021-12-02T16:13:40+00:00 https://destinypharma.com/news-and-media/media-coverage/professor-dale-gerding-a-world-leader-in-c-difficile-infections-speaks-to-equity-development-about-the-significant-problem-of-cdi-and-how-destiny-pharmas-novel-ntcd-m3-clinical-programme-ca/ 2023-04-20T15:46:59+00:00 https://destinypharma.com/2021/11/26/26-november-2021-sab-member-prof-gerding-interviewed-by-equity-development/ 2023-03-20T10:20:38+00:00 https://destinypharma.com/2021/11/24/24-november-2021-destiny-pharma-highlighted-in-whi-ireland-analyst-note/ 2023-03-20T10:20:51+00:00 https://destinypharma.com/news-and-media/events/german-equity-forum-22-24-november-2021/ 2021-11-17T10:50:42+00:00 https://destinypharma.com/news-and-media/events/emerging-antimicrobials-and-diagnostics-in-amr-2021-eada-2021-18-november-2021/ 2021-11-16T12:29:41+00:00 https://destinypharma.com/news-and-media/media-coverage/destiny-pharma-presentation-on-ntcd-m3-to-the-9th-annual-international-c-diff-conference-health-expo/ 2023-04-20T15:48:53+00:00 https://destinypharma.com/2021/11/04/04-november-2021-sab-member-prof-gerding-is-keynote-at-c-diff-conference/ 2023-03-20T10:21:14+00:00 https://destinypharma.com/news-and-media/events/jefferies-london-healthcare-conference-16-18-november-2021/ 2021-10-20T15:51:52+00:00 https://destinypharma.com/news-and-media/events/c-diff-international-conference-health-expo-4-5-november-2021-2/ 2021-10-20T15:50:28+00:00 https://destinypharma.com/2021/10/18/18-october-2021-major-us-hospital-based-clinical-trial-highlights-benefit-of-nasal-decolonization-to-reduce-icu-infections-caused-by-staphylococcus-aureus/ 2023-03-20T10:21:56+00:00 https://destinypharma.com/news-and-media/media-coverage/alan-green-talks-to-ceo-neil-clark/ 2023-04-20T15:48:59+00:00 https://destinypharma.com/2021/10/11/11-october-2021-idsa-press-release-drug-resistant-infections-led-to-1-9-billion-in-health-care-costs-more-than-10000-deaths-among-older-adults-in-one-year/ 2023-03-20T10:22:21+00:00 https://destinypharma.com/2021/09/27/27-september-2021-expansion-of-clinical-pipeline/ 2023-03-20T10:22:44+00:00 https://destinypharma.com/news-and-media/media-coverage/destiny-pharma-presentation-at-the-proactive-one2one-virtual-forum-2/ 2023-04-20T15:49:06+00:00 https://destinypharma.com/2021/09/09/9-sep-2021-interim-results-for-the-6-months-ended-30-june-2021/ 2023-03-20T10:23:06+00:00 https://destinypharma.com/2021/08/23/26-august-2021-notice-of-interim-results-and-investor-presentation/ 2023-03-20T10:23:21+00:00 https://destinypharma.com/news-and-media/events/bio-europe-digital-25-28-october-2021/ 2021-08-17T11:16:26+00:00 https://destinypharma.com/news-and-media/events/id-week-29-september-3-october-2021/ 2021-08-17T11:15:53+00:00 https://destinypharma.com/news-and-media/events/proactive-one2one-virtual-forum-16th-september-2021/ 2021-08-17T11:12:24+00:00 https://destinypharma.com/news-and-media/media-coverage/destiny-pharma-publish-more-evidence-of-surgery-nasal-gel-effectiveness/ 2023-04-20T15:49:13+00:00 https://destinypharma.com/2021/08/02/02-august-2021-secondary-endpoint-analysis-from-phase-2b-trial/ 2023-03-20T10:28:28+00:00 https://destinypharma.com/news-and-media/media-coverage/voiceamericatrn-c-diff-spores-and-more-radio-programme-recorded-20th-july-at-1800-bst/ 2023-04-20T15:49:20+00:00 https://destinypharma.com/2021/07/09/09-july-2021-xf-73-phase-2b-data-to-be-presented-at-eccmid/ 2023-03-20T10:28:49+00:00 https://destinypharma.com/news-and-media/media-coverage/destiny-pharma-presentation-at-the-shares-investor-evening-6th-july-2021/ 2023-04-20T15:49:28+00:00 https://destinypharma.com/news-and-media/events/5th-amr-conference-summer-edition-amr-briefing-sessions-24-26-august-2021/ 2021-07-08T12:25:26+00:00 https://destinypharma.com/2021/07/02/02-july-2021-scientific-advisor-professor-dale-gerding-to-chair-c-diff-foundation-symposium/ 2023-03-20T11:40:21+00:00 https://destinypharma.com/news-and-media/events/eccmid-2021-9-12-july-2021/ 2021-06-29T08:17:14+00:00 https://destinypharma.com/news-and-media/events/shares-aj-bell-webinar-6-july-2021/ 2021-06-29T07:49:09+00:00 https://destinypharma.com/2021/06/29/29-june-2021-destiny-pharma-to-present-at-shares-aj-bell-webinar-6th-july-2021/ 2023-03-20T10:32:08+00:00 https://destinypharma.com/2021/06/10/10-june-2021-xf-73-data-abstract-to-be-presented-at-2021-eccmid/ 2023-03-20T10:32:16+00:00 https://destinypharma.com/news-and-media/media-coverage/destiny-pharma-presentation-at-the-cenkos-growth-and-innovation-forum/ 2023-04-20T15:50:03+00:00 https://destinypharma.com/2021/06/07/07-june-2021-destiny-pharma-welcomes-g7s-communique-on-antimicrobial-resistance/ 2023-03-20T11:55:26+00:00 https://destinypharma.com/2021/06/04/3550/ 2023-03-20T10:32:32+00:00 https://destinypharma.com/news-and-media/media-coverage/destiny-pharma-consultant-professor-dale-gerding-updates-on-recurrent-c-difficile-infections-work/ 2023-04-20T15:50:11+00:00 https://destinypharma.com/2021/05/25/25-may-2021-further-information-re-agm/ 2023-03-20T11:57:41+00:00 https://destinypharma.com/news-and-media/events/microbiome-movement-drug-development-29-june-1-july-2021/ 2021-05-19T17:40:04+00:00 https://destinypharma.com/news-and-media/events/bio-international-convention-14-18-june-2021/ 2021-05-19T17:31:51+00:00 https://destinypharma.com/2021/05/19/19-may-2021-notice-to-register-for-2021-agm/ 2023-03-20T11:57:46+00:00 https://destinypharma.com/2021/05/06/06-may-2021-destiny-pharma-conference-attendance-for-may-2021/ 2023-03-20T11:57:53+00:00 https://destinypharma.com/2021/05/04/04-may-2021-posting-of-annual-report-and-notice-of-agm/ 2023-03-20T11:58:07+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-to-present-at-bio-equity-europe-conference-17-19-may-2021/ 2021-04-21T16:59:52+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-to-present-at-the-proactive-one2one-virtual-forum-6-may-2021/ 2021-04-21T16:58:04+00:00 https://destinypharma.com/news-and-media/media-coverage/proactive-results-interview/ 2023-04-20T15:50:57+00:00 https://destinypharma.com/2021/04/15/15-apr-2021-investor-presentation-22-april-2021-at-1400-bst/ 2023-03-20T11:58:13+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-to-present-at-the-pharmabiotics-conference-28-29-april-2021/ 2021-04-14T15:15:15+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-to-present-at-the-2021-digital-bioinfect-conference-21-22-april-2021/ 2021-04-14T15:12:00+00:00 https://destinypharma.com/2021/04/14/14-apr-2021-audited-results-for-the-year-ended-31-december-2020-and-positive-phase-2b-data-announced-post-year-end/ 2023-03-20T11:58:24+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-to-present-at-the-5th-future-healthcare-vb100-conference-16-18-april-2021-in-suzhou-jiangsu-province-china/ 2021-04-12T20:27:54+00:00 https://destinypharma.com/news-and-media/media-coverage/developing-novel-medicines-that-prevent-serious-infections/ 2023-04-20T15:51:06+00:00 https://destinypharma.com/2021/03/29/29-mar-2021-destiny-pharma-to-join-equity-development-webinar/ 2023-03-20T11:58:30+00:00 https://destinypharma.com/2021/03/29/29-mar-2021-destiny-pharma-phase-2b-results-analyst-and-investor-webcast-and-conference-call-details-monday-29th-march-at-1100-bst/ 2021-03-29T08:30:08+00:00 https://destinypharma.com/2021/03/29/29-mar-2021-destiny-pharma-reports-positive-phase-2b-results-for-xf-73-nasal-gel/ 2023-03-20T12:16:59+00:00 https://destinypharma.com/2021/03/16/16-mar-2021-notice-of-full-year-results-and-clinical-trial-update/ 2023-03-16T11:07:19+00:00 https://destinypharma.com/2021/03/15/15-mar-2021-destiny-pharma-announces-agreement-with-niaid/ 2023-03-16T11:07:19+00:00 https://destinypharma.com/news-and-media/media-coverage/proactive-elevator-pitch/ 2023-04-20T15:51:12+00:00 https://destinypharma.com/2021/03/10/10-mar-2021-destiny-pharma-cso-joins-ukri-covid-19-taskforce/ 2023-03-16T11:07:19+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-to-attend-bio-europe-spring-22-25-march-2021/ 2021-02-26T10:43:27+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-to-present-at-14th-annual-european-life-sciences-ceo-forum-10-11-march-2021/ 2021-02-26T10:42:42+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-to-attend-h-c-wainwright-global-life-sciences-conference-on-9-10-march-2021/ 2021-02-26T10:41:30+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-to-present-at-the-shares-investor-evening-webinar-3rd-february-2021/ 2021-02-03T11:29:18+00:00 https://destinypharma.com/2021/02/03/03-feb-2021-destiny-pharma-announces-brazilian-patent-granted-for-xf-73-nasal-gel/ 2023-03-16T11:07:19+00:00 https://destinypharma.com/2021/02/02/02-feb-2021-destiny-pharma-to-join-panel-discussion-at-the-7th-annual-lsx-world-congress-2021/ 2023-03-16T11:07:19+00:00 https://destinypharma.com/2021/02/02/02-feb-2021-destiny-pharma-appoints-professor-mark-wilcox/ 2023-03-16T11:07:19+00:00 https://destinypharma.com/news-and-media/media-coverage/destiny-pharma-presents-an-overview-of-the-company-at-the-shares-spotlight-investor-evening/ 2023-04-21T11:51:30+00:00 https://destinypharma.com/2021/01/27/27-jan-2021-destiny-pharma-welcomes-matt-hancocks-attention-to-amr/ 2021-01-27T13:29:58+00:00 https://destinypharma.com/2021/01/21/21-jan-2021-destiny-pharma-investor-presentation/ 2021-01-21T11:21:09+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-to-present-at-lsx-world-congress-1-5-february-2021/ 2021-01-15T16:59:11+00:00 https://destinypharma.com/2021/01/06/06-jan-2021-destiny-pharma-appoints-stephanie-bewick-as-chief-business-officer/ 2023-03-16T11:07:19+00:00 https://destinypharma.com/2021/01/05/05-jan-2021-phase-2b-trial-of-xf-73-completes-recruitment/ 2023-03-16T11:07:19+00:00 https://destinypharma.com/news-and-media/media-coverage/proactive-one2one-investor-forum-thursday-january-21st-from-600-pm-gmt/ 2023-04-21T11:52:58+00:00 https://destinypharma.com/news-and-media/media-coverage/destiny-pharma-presents-at-the-proactive-one2one-live-investment-forum/ 2023-04-21T11:52:36+00:00 https://destinypharma.com/news-and-media/media-coverage/neil-clark-talks-to-proactive-londons-katie-pilbeam-about-the-xf-73-phase-2b-clinical-trial-which-is-now-fully-recruited/ 2023-04-21T11:51:58+00:00 https://destinypharma.com/2020/12/21/21-dec-2020-destiny-pharma-joins-the-pharmabiotic-research-institute-pri/ 2020-12-21T08:59:48+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-to-present-at-biotech-showcase-conference-11-15-january-2021/ 2020-11-27T12:28:48+00:00 https://destinypharma.com/2020/11/26/26-nov-2020-destiny-pharma-result-of-general-meeting-and-total-voting-rights/ 2023-03-16T11:07:18+00:00 https://destinypharma.com/2020/11/25/25-nov-2020-destiny-pharma-announces-total-gross-proceeds-raised-via-open-offer/ 2023-03-16T11:07:18+00:00 https://destinypharma.com/2020/11/18/18-nov-2020-antibiotic-resistance-a-matter-of-time-ft/ 2020-11-18T11:46:57+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-to-attend-jefferies-virtual-london-healthcare-conference-17-19-november-2020/ 2020-11-16T14:02:21+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-is-supporting-world-antimicrobial-resistance-amr-awareness-week-18-24-november-2020/ 2020-11-16T12:12:40+00:00 https://destinypharma.com/2020/11/13/note-to-shareholders/ 2020-11-13T17:31:57+00:00 https://destinypharma.com/2020/11/11/circular-to-shareholders-dated-10-november-2020/ 2020-11-11T12:03:47+00:00 https://destinypharma.com/2020/11/11/open-offer-application-form-2/ 2020-11-11T12:00:26+00:00 https://destinypharma.com/2020/11/09/09-nov-2020-fundraising-announcement-2/ 2020-11-09T17:07:55+00:00 https://destinypharma.com/2020/11/09/09-nov-2020-fundraising-announcement/ 2020-11-09T16:56:07+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-to-attend-ewma-virtual-2020-conference-18-19-november-2020/ 2020-10-19T13:41:10+00:00 https://destinypharma.com/2020/10/12/12-oct-2020-clinical-study-patient-recruitment-update/ 2023-03-16T11:07:18+00:00 https://destinypharma.com/2020/10/01/destiny-pharma-welcomes-proposed-pasteur-act-in-usa/ 2020-10-01T13:40:54+00:00 https://destinypharma.com/2020/09/17/17-sep-2020-update-on-phase-2b-clinical-study-of-lead-asset-xf-73-in-the-prevention-of-post-surgical-infections/ 2023-03-16T11:07:18+00:00 https://destinypharma.com/2020/09/17/17-sep-2020-interim-results-for-the-6-months-ended-30-june-2020/ 2023-03-16T11:07:18+00:00 https://destinypharma.com/2020/09/10/10-sep-2020-scrip-article-destiny-pharma-and-sporegen-back-nasal-spray-over-vaccine-to-tackle-covid-19/ 2020-09-10T09:34:55+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-to-attend-bio-europe-digital-26-29-october-2020/ 2020-09-09T16:04:20+00:00 https://destinypharma.com/2020/09/07/07-september-2020-destiny-pharma-and-sporegen-announce-collaboration-and-innovate-uk-grant-award-to-co-develop-novel-preventative-treatment-for-covid-19/ 2023-03-16T11:07:18+00:00 https://destinypharma.com/2020/08/17/17-aug-2020-destiny-pharma-welcomes-nbic-biofilmaware-campaign-launched-today/ 2020-08-17T07:21:12+00:00 https://destinypharma.com/2020/08/11/11-aug-2020-positive-interim-safety-review-of-phase-2b-clinical-trial-of-lead-asset-xf-73-in-the-prevention-of-post-surgical-bacterial-infections/ 2023-03-16T11:07:18+00:00 https://destinypharma.com/2020/08/07/07-aug-2020-could-drug-resistant-bacteria-cause-the-next-pandemic-forbes/ 2020-08-07T11:42:56+00:00 https://destinypharma.com/2020/08/05/05-aug-2020-neil-clark-ceo-interviewed-by-equity-development/ 2020-08-05T11:49:21+00:00 https://destinypharma.com/2020/07/27/27-july-2020-update-on-phase-2b-clinical-study-of-xf-73/ 2023-03-16T11:07:18+00:00 https://destinypharma.com/2020/07/10/10-july-2020-pharma-companies-join-forces-to-launch-1-billion-fund-to-develop-new-antibiotics-by-2030/ 2020-07-10T09:59:17+00:00 https://destinypharma.com/2020/06/10/10-june-2020-result-of-annual-general-meeting/ 2023-03-16T11:07:18+00:00 https://destinypharma.com/2020/06/09/09-june-2020-destiny-pharma-awarded-grant-to-fund-collaboration-with-cardiff-university-targeting-fungal-infections/ 2023-03-16T11:07:18+00:00 https://destinypharma.com/2020/05/12/12-may-2020-posting-of-annual-report-and-notice-of-agm/ 2023-03-16T11:07:18+00:00 https://destinypharma.com/2020/05/07/07-may-2020-director-of-preclinical-development-as-panel-member-for-ktn-antimicrobial-resistance-global-expert-mission-dissemination-seminar/ 2020-05-07T17:02:19+00:00 https://destinypharma.com/2020/05/06/06-may-2020-ft-article-highlights-coronavirus-lessons-for-the-fight-against-superbugs/ 2020-05-06T10:09:31+00:00 https://destinypharma.com/2020/05/04/04-may-2020-independent-review-supports-the-potential-of-xf-73/ 2023-03-16T11:07:18+00:00 https://destinypharma.com/2020/04/29/29-apr-2020-audited-results-for-the-year-ended-31-december-2019-and-clinical-development-update/ 2020-04-29T06:59:56+00:00 https://destinypharma.com/2020/04/08/8-apr-2020-destiny-pharma-featured-in-endpoints-news/ 2020-04-08T11:05:13+00:00 https://destinypharma.com/2020/04/02/antibiotic-resistance-could-lead-to-more-covid-19-deaths/ 2020-04-02T09:16:22+00:00 https://destinypharma.com/2020/03/03/03-mar-2020-clinical-and-business-update/ 2023-03-16T11:07:18+00:00 https://destinypharma.com/2020/02/21/effectiveness-of-cancer-treatments-threatened-by-rising-antibiotic-resistance/ 2020-02-21T13:12:29+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-to-attend-eccmid-2020-18-21-april-2020-paris-france-2/ 2020-02-21T12:03:57+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-to-attend-eccmid-2020-18-21-april-2020-paris-france/ 2020-02-21T11:57:19+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-to-attend-4th-amr-conference-novel-antimicrobials-and-amr-diagnostics-12-13-march-2020-basel-switzerland-2/ 2020-02-07T14:53:50+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-to-attend-infection-control-2020-13-february-2020-birmingham-uk-2/ 2020-02-07T14:51:57+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-to-attend-the-2020-bioinfect-conference-12th-february-2020-alderley-park-uk/ 2020-02-07T14:49:10+00:00 https://destinypharma.com/2020/01/22/destiny-pharma-to-attend-4th-amr-conference-novel-antimicrobials-and-amr-diagnostics-12-13-march-2020-basel-switzerland/ 2020-01-22T13:59:29+00:00 https://destinypharma.com/2020/01/22/destiny-pharma-to-attend-infection-control-2020-13-february-2020-birmingham-uk/ 2020-01-22T13:50:16+00:00 https://destinypharma.com/2020/01/22/22-jan-2020-proactive-interview-destiny-pharma-awaits-key-inflection-point-mid-2020-in-its-antimicrobial-phase-2b-clinical-trial/ 2020-01-22T10:16:56+00:00 https://destinypharma.com/2020/01/20/20-jan-2020-positive-update-on-the-development-of-new-xf-platform-drug-formulations/ 2023-03-16T11:07:18+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-to-present-at-lsx-world-congress-2020-4th-february-2020-london-uk-2/ 2020-01-07T16:22:02+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-to-present-at-jpm-biotech-showcase-2020-13-15-january-2020-san-francisco-usa/ 2020-01-07T16:21:24+00:00 https://destinypharma.com/2020/01/07/destiny-pharma-to-present-at-lsx-world-congress-2020-4th-february-2020-london-uk/ 2020-01-07T16:16:12+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-to-present-at-bfc-global-healthcare-investment-conference-12-january-2020-san-francisco-usa/ 2020-01-07T16:11:21+00:00 https://destinypharma.com/2019/12/17/17-dec-2019-apsic-guidelines-recommend-decolonising-s-aureus/ 2023-03-16T11:07:18+00:00 https://destinypharma.com/2019/12/02/02-dec-2019-destiny-pharma-to-present-at-the-partnerships-to-tackle-the-global-challenge-of-amr-uk-china-amr-workshop/ 2023-03-16T11:07:18+00:00 https://destinypharma.com/2019/12/02/02-dec-2019-directorate-change/ 2023-03-16T11:07:18+00:00 https://destinypharma.com/2019/11/29/destiny-pharma-to-attend-jpm-biotech-showcase-2020-13-15-january-2020-san-francisco-usa/ 2019-11-29T10:27:10+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-to-attend-rsc-novel-strategies-for-combatting-antibacterial-resistance-event-9-december-2019-london-uk/ 2019-11-22T17:04:41+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-to-attend-uk-china-amr-workshop-2019-on-3-5-december-2019-in-beijing-china/ 2019-11-22T16:57:26+00:00 https://destinypharma.com/2019/11/15/15-nov-2019-destiny-pharma-to-present-at-the-invetival-showcase-in-partnership-with-jefferies/ 2023-03-16T11:07:18+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-to-present-at-emerging-antimicrobials-and-diagnostics-in-amr-2019-on-19-20-november-2019-in-amsterdam/ 2019-11-14T15:36:29+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-to-attend-jefferies-2019-london-healthcare-conference-on-20-21-november-2019-in-london-uk/ 2019-11-14T15:32:14+00:00 https://destinypharma.com/2019/11/06/06-nov-2019-destiny-pharma-to-present-at-the-world-anti%e2%80%90microbial-resistance-congress-2019/ 2023-03-16T11:07:18+00:00 https://destinypharma.com/2019/10/16/16-oct-2019-destiny-pharma-positive-results-published-from-an-independent-us-national-institute-of-health-xf-73-phase-1-clinical-trial-in-a-peer-reviewed-journal/ 2023-03-16T11:07:18+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-to-present-at-world-anti-microbial-resistance-congress-2019-7-8-november-2019-washington-dc-usa/ 2019-10-09T15:17:33+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-to-present-at-life-science-ip-26-27-november-2019-london-uk/ 2019-10-09T14:21:19+00:00 https://destinypharma.com/2019/09/24/24-sep-2019-destiny-pharma-interims-presentation-and-audio-recording/ 2019-09-24T12:56:40+00:00 https://destinypharma.com/2019/09/23/23-sep-2019-directorate-change/ 2023-03-16T11:07:18+00:00 https://destinypharma.com/2019/09/23/23-sep-2019-interim-results-for-the-6-months-ended-30-june-2019/ 2023-03-16T11:07:18+00:00 https://destinypharma.com/2019/09/11/public-health-england-announced-its-new-strategy-to-address-amr/ 2019-09-11T13:35:26+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-to-attend-bio-europe-2019-11-13-november-2019-in-hamburg-germany/ 2019-09-10T10:42:05+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-to-attend-cphi-europe-5-7-november-2019-in-frankfurt-germany/ 2019-09-10T10:27:33+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-to-attend-idweek-2019-2-6-october-2019-in-washington-dc-usa/ 2019-09-10T09:20:47+00:00 https://destinypharma.com/2019/09/10/10-sep-2019-destiny-pharma-awarded-grant-to-fund-a-research-collaboration-with-the-university-of-sheffield-targeting-ophthalmic-bacterial-and-fungal-infections-2/ 2023-03-16T11:07:18+00:00 https://destinypharma.com/2019/09/02/2nd-sept-2019-destiny-pharma-xf-drug-platform-data-to-be-presented-at-eurobiofilms/ 2023-03-16T11:07:18+00:00 https://destinypharma.com/2019/08/16/15-aug-2019-change-in-shareholding/ 2019-08-16T08:42:55+00:00 https://destinypharma.com/2019/08/05/05-aug-2019-destiny-pharma-welcomes-the-us-governments-healthcare-reform-for-novel-antibacterial-drug-payments/ 2019-08-05T11:06:37+00:00 https://destinypharma.com/news-and-media/events/31-jul-2019-destiny-pharma-to-present-at-the-2019-gordon-research-conference-4-9-august-2019/ 2019-07-31T07:29:23+00:00 https://destinypharma.com/news-and-media/events/17-jul-2019-destiny-pharma-to-attend-eurobiofilms-2019-3-6-september-2019-in-glasgow-scotland/ 2019-07-17T12:19:01+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-to-attend-asm-escmid-conference-on-drug-development-to-meet-the-challenge-of-antimicrobial-resistance-4-6-september-2019-in-boston-usa/ 2019-07-17T12:11:05+00:00 https://destinypharma.com/2019/07/10/10-jul-2019-development-of-new-antibiotics-encouraged-with-new-pharmaceutical-payment-system/ 2019-07-10T09:15:38+00:00 https://destinypharma.com/news-and-media/events/26-jun-2019-destiny-pharma-participated-in-the-uk-global-expert-mission-antimicrobial-resistance-germany/ 2019-06-26T12:07:35+00:00 https://destinypharma.com/2019/06/05/04-jun-2019-result-of-agm/ 2019-06-05T18:07:06+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-to-attend-obn-biotuesday-on-tuesday-16th-july-2019-in-manchester-uk/ 2019-06-05T15:50:09+00:00 https://destinypharma.com/2019/06/05/destiny-pharma-are-part-of-the-uk-government-global-expert-mission-delegation-to-germany-20-24-may-2019/ 2019-06-05T15:44:49+00:00 https://destinypharma.com/2019/06/05/pharmafocus-publish-article-the-global-rise-in-antibiotic-resistance-threatens-infection-prevention-and-cure/ 2019-06-05T15:27:03+00:00 https://destinypharma.com/2019/06/05/destiny-pharma-appoints-nomad-and-joint-broker/ 2019-06-05T15:15:25+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-to-present-at-the-us-china-bio-partnering-forum-30-31-may-2019-chicago-usa/ 2019-06-05T15:07:49+00:00 https://destinypharma.com/2019/06/05/destiny-pharma-welcomes-united-nations-report/ 2019-06-05T14:17:44+00:00 https://destinypharma.com/2019/06/05/posting-of-accounts-and-notice-of-agm-2/ 2019-06-05T13:56:42+00:00 https://destinypharma.com/2019/04/16/equity-development-publish-latest-research-note-destiny-pharma-bucking-the-big-pharma-trend/ 2019-04-16T15:49:40+00:00 https://destinypharma.com/2019/04/15/destiny-pharma-welcomes-new-beam-alliance-paper-a-new-vision-for-amr-innovation-to-support-medical-care/ 2019-04-15T09:15:47+00:00 https://destinypharma.com/2019/04/11/destiny-pharma-2018-final-results-finncap-and-edison-latest-published-research-april-2019/ 2019-04-11T19:30:18+00:00 https://destinypharma.com/2019/04/09/audited-results-for-the-year-ended-31-december-2018/ 2023-03-16T11:07:18+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-to-attend-bioequity-europe-2019-20-21-may-2019-barcelona-spain/ 2019-03-27T10:51:36+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-to-attend-biotrinity-2019-30-april-1-may-2019-london-uk/ 2019-03-27T10:49:02+00:00 https://destinypharma.com/2019/03/27/medpharm-to-develop-new-xf-drug-formulations/ 2023-03-16T11:07:18+00:00 https://destinypharma.com/2019/03/22/notice-of-full-year-results/ 2023-03-16T11:07:18+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-to-attend-european-congress-of-clinical-microbiology-and-infectious-diseases-eccmid-13-16-april-2019-amsterdam-netherlands/ 2019-03-19T12:49:17+00:00 https://destinypharma.com/2019/02/25/edison-investment-research-publish-research-note-on-destiny-pharma-entitled-prevention-is-commercially-cost-effective/ 2019-02-25T13:55:27+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-to-attend-bio-europe-spring-25-27-march-2019-in-vienna-austria/ 2019-02-17T22:06:54+00:00 https://destinypharma.com/2019/01/30/neil-clark-ceo-interviewed-at-proactive-investor-event-on-28-january-2019/ 2019-01-30T11:27:41+00:00 https://destinypharma.com/2019/01/28/second-positive-phase-1-trial-data-for-xf-73/ 2019-01-28T09:04:17+00:00 https://destinypharma.com/2019/01/25/destiny-awarded-new-uk-china-amr-grant/ 2019-01-25T07:40:00+00:00 https://destinypharma.com/2019/01/24/destiny-pharma-notes-uk-5-year-action-plan-on-amr/ 2019-01-24T12:08:34+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-to-attend-superbugs-superdrugs-2019-18-19-march-2019-london-uk/ 2019-01-17T22:40:56+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-to-attend-novel-antimicrobials-and-amr-diagnostics-2019-14-15-march-2019-berlin-germany/ 2019-01-17T22:40:01+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-to-attend-ukri-amr-house-of-commons-event-13-february-2019-london-uk/ 2019-01-17T22:38:42+00:00 https://destinypharma.com/2018/11/07/destiny-pharma-notes-daily-telegraph-coverage-on-antibiotic-resistance/ 2018-11-07T13:57:44+00:00 https://destinypharma.com/2018/11/01/destiny-pharma-announces-research-collaboration-with-the-university-of-southampton-targeting-infections-in-diabetic-foot-ulcers-and-cystic-fibrosis/ 2023-03-16T11:07:18+00:00 https://destinypharma.com/2018/10/25/directorate-change-2/ 2023-03-16T11:07:18+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-to-attend-2018-bioinfect-conference-november-8th-2018-cheshire-uk/ 2018-10-24T10:20:30+00:00 https://destinypharma.com/2018/10/24/uk-government-highlights-global-threat-of-amr/ 2018-10-24T08:00:07+00:00 https://destinypharma.com/2018/10/19/bia-celebrates-uk-bioscience-innovative/ 2018-10-19T08:30:51+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-to-attend-biotech-showcase-january-7th-9th-2019-san-francisco-usa/ 2018-10-15T13:40:45+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-to-attend-biojapan-10-12-october-2018-pacifico-yokohama-japan/ 2018-10-05T12:53:27+00:00 https://destinypharma.com/2018/09/26/destiny-pharma-appoints-cmo/ 2023-03-16T11:07:18+00:00 https://destinypharma.com/2018/09/26/interim-results-for-the-6-months-ended-30-june-2018/ 2023-03-16T11:07:18+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-to-attend-cphi-9-11-october-2018-feria-de-madrid-spain/ 2018-09-07T13:19:29+00:00 https://destinypharma.com/2018/09/06/directorate-change/ 2023-03-16T11:07:18+00:00 https://destinypharma.com/2018/07/26/destiny-pharma-announces-positive-data-from-xf-73-phase-1-skin-irritation-study/ 2023-03-16T11:07:18+00:00 https://destinypharma.com/2018/07/17/research-collaboration-with-aston-university-to-investigate-new-xf-platform-drug-candidates/ 2018-07-17T17:11:26+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-to-attend-id-week-3-7-october-2018-in-san-francisco-usa/ 2018-07-06T22:26:33+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-to-present-at-shares-investor-event-10th-july-2018-in-london-uk/ 2018-07-05T20:14:34+00:00 https://destinypharma.com/2018/07/03/destiny-pharma-welcomes-significant-pull-incentive/ 2018-07-03T11:31:37+00:00 https://destinypharma.com/2018/06/14/destiny-pharma-notes-fda-statement-on-their-focus-to-enable-new-approaches-to-fight-amr/ 2018-06-14T07:13:01+00:00 https://destinypharma.com/2018/05/30/scientific-advisory-board/ 2018-05-30T09:43:29+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-to-attend-bio-europe-2018-november-5-7-2018-in-copenhagen-denmark/ 2018-05-08T13:40:19+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-to-attend-asm-microbe-2018-june-7-11-2018-in-atlanta-usa/ 2018-05-08T13:24:35+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-to-speak-at-the-second-meeting-of-the-uk-bioindustry-associations-china-special-interest-group/ 2018-04-27T12:16:14+00:00 https://destinypharma.com/2018/04/23/posting-of-accounts-and-notice-of-agm/ 2023-03-16T11:07:18+00:00 https://destinypharma.com/2018/04/12/clinical-update/ 2023-03-16T11:07:18+00:00 https://destinypharma.com/2018/04/12/audited-results-for-the-year-ended-31-december-2017/ 2023-03-16T11:07:17+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-attending-international-conference-on-porphyrins-and-phthalocyanines-icpp-in-munich-germany-from-1st-6th-july-2018/ 2018-03-29T14:23:20+00:00 https://destinypharma.com/2018/03/23/cost-of-antibiotic-resistant-infections-in-u-s-tops-2b-per-year/ 2018-03-23T12:16:07+00:00 https://destinypharma.com/2018/03/23/destiny-pharma-to-announce-financial-results-for-the-year-ended-31-december-2017-on-thursday-12-april-2018/ 2018-03-23T09:10:50+00:00 https://destinypharma.com/2018/03/22/appointment-of-joint-broker/ 2018-03-22T11:58:05+00:00 https://destinypharma.com/2018/03/15/destiny-pharma-announces-fda-fast-track-designation-for-lead-clinical-candidate-exeporfinium-chloride-xf-73/ 2023-03-16T11:07:17+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-attending-eccmid-2018-in-madrid-spain-from-21st-24th-april-2018/ 2018-03-13T12:28:03+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-attending-superbugs-and-superdrugs-2018-in-london-from-19th-20th-march-2018/ 2018-03-12T14:46:45+00:00 https://destinypharma.com/2018/02/26/destiny-pharma-opens-ind-for-its-novel-anti-infective-drug-xf-73-ahead-of-commencing-us-clinical-trials/ 2023-03-16T11:07:17+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-attending-the-11th-berlin-conference-on-life-sciences-novel-antimicrobials-and-amr-diagnostics-on-2-march-2018/ 2018-02-23T13:49:17+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-attending-bioeurope-spring-2018-in-amsterdam-from-12th-14th-march-2018/ 2018-02-14T14:04:51+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-presenting-at-the-guinness-aim-investor-seminar-in-london-on-22nd-february-2018/ 2018-02-10T07:45:55+00:00 https://destinypharma.com/2018/02/05/destiny-pharma-wins-deal-of-the-year-at-the-insider-south-east-dealmaker-awards-2018/ 2018-02-05T09:23:14+00:00 https://destinypharma.com/2018/01/29/1bn-rewards-proposed-at-davos-2018-for-new-antibiotics/ 2018-01-29T09:26:33+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-attending-the-biotech-and-money-world-congress-in-london-on-5th-6th-february-2018/ 2018-01-18T15:54:26+00:00 https://destinypharma.com/2018/01/09/equity-development-initiates-coverage-of-destiny-pharma/ 2018-01-09T16:10:55+00:00 https://destinypharma.com/2017/12/01/china-medical-system-holdings-limited-invests-3-0-million-in-destiny-pharma/ 2023-03-16T11:07:17+00:00 https://destinypharma.com/2017/12/01/regional-development-and-commercialisation-agreement-finalised-with-china-medical-system-holdings-limited/ 2023-03-16T11:07:17+00:00 https://destinypharma.com/2017/10/30/mrsa-superbug-spreading-from-hospitals-across-uk/ 2017-10-30T15:16:08+00:00 https://destinypharma.com/2017/10/09/united-nations-group-to-meet-in-berlin-in-october-2017-to-discuss-global-issue-of-anti-microbial-resistance/ 2017-10-09T09:33:18+00:00 https://destinypharma.com/2017/09/27/destiny-pharma-to-push-ahead-with-next-generation-antibiotic-after-15-million-ipo/ 2017-09-27T18:26:32+00:00 https://destinypharma.com/2017/09/27/destiny-pharma-announce-interim-results-27th-september-2017/ 2017-09-27T17:02:08+00:00 https://destinypharma.com/2017/09/19/more-support-announced-for-new-antibiotics/ 2017-09-19T16:34:52+00:00 https://destinypharma.com/2017/09/04/framework-agreement-with-china-medical-systems/ 2023-03-16T11:07:17+00:00 https://destinypharma.com/2017/09/04/admission-and-first-day-of-dealings-on-aim/ 2023-03-16T11:07:17+00:00 https://destinypharma.com/2017/09/01/destiny-pharma-plc-publishes-supplementary-aim-admission-document/ 2017-09-01T18:39:45+00:00 https://destinypharma.com/2017/08/29/destiny-pharma-plc-publishes-aim-admission-document/ 2017-08-29T21:39:29+00:00 https://destinypharma.com/2017/08/18/notification-of-intention-to-admit-shares-to-trading-on-the-alternative-investment-market-of-the-london-stock-exchange/ 2023-03-16T11:07:17+00:00 https://destinypharma.com/2017/07/13/g20-declaration-on-combatting-antimicrobial-resistance-amr-7-8th-july-2017/ 2017-07-13T15:48:17+00:00 https://destinypharma.com/2017/07/07/to-the-g20-incentivise-antibacterial-drug-rd/ 2017-07-07T13:57:45+00:00 https://destinypharma.com/2017/07/07/destinys-brainchild-south-east-business-magazine/ 2017-07-07T11:42:23+00:00 https://destinypharma.com/2017/06/14/regulators-from-eu-u-s-and-japan-join-forces-on-antimicrobial-trials/ 2017-06-14T11:24:34+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-in-attendance-at-the-18th-bioequity-europe-meeting-paris-france/ 2017-05-19T09:11:55+00:00 https://destinypharma.com/2017/05/09/destiny-board-member-elected-to-the-academy-of-medical-sciences/ 2023-03-16T11:07:17+00:00 https://destinypharma.com/2017/04/13/destiny-pharma-announces-appointment-of-new-ceo/ 2023-03-16T11:07:17+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-to-attend-the-27th-european-congress-of-clinical-microbiology-and-infectious-diseases-eccmid-in-vienna-austria/ 2017-04-12T11:17:59+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-to-attend-bio-europe-meeting-barcelona-spain/ 2017-03-07T16:25:14+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-to-present-at-the-18th-bioequity-europe-meeting-paris-france/ 2017-02-17T12:56:52+00:00 https://destinypharma.com/2016/12/16/21st-century-cures-act-signed-into-law-by-president-obama/ 2016-12-16T15:06:44+00:00 https://destinypharma.com/2016/11/30/destiny-pharma-ceo-appointed-to-the-board-of-gamrif/ 2016-11-30T15:05:31+00:00 https://destinypharma.com/2016/10/31/wellcome-trust-report-on-boosting-development-of-new-antimicrobial-drugs/ 2016-10-31T13:35:27+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-to-attend-idweek-in-new-orleans-louisiana/ 2016-10-18T14:15:36+00:00 https://destinypharma.com/2016/09/21/momentous-step-taken-by-un-to-fight-antibiotic-resistance-welcomed-by-destiny-pharma/ 2023-03-16T11:07:17+00:00 https://destinypharma.com/2016/09/05/novel-antibacterial-drug-exeporfinium-chloride-delivers-encouraging-safety-tolerability-and-efficacy-data-in-us-clinical-trial/ 2023-03-16T11:07:17+00:00 https://destinypharma.com/2016/08/24/destiny-pharma-expert-view-published-in-the-pharma-letter/ 2016-08-24T09:05:34+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-invited-to-present-at-the-inaugural-superbugs-superdrugs-usa-conference-exhibition-on-the-14th-and-15th-november-2016-in-new-jersey-usa/ 2016-07-08T11:17:23+00:00 https://destinypharma.com/2016/05/19/19th-may-2016-destiny-pharma-welcomes-oneill-report-on-tackling-antimicrobial-resistance-amr/ 2023-03-16T11:07:17+00:00 https://destinypharma.com/2016/03/18/destiny-pharma-in-the-news/ 2016-03-18T11:27:26+00:00 https://destinypharma.com/2016/01/26/destiny-pharma-sign-declaration-to-fight-antibiotic-resistance/ 2016-01-26T11:28:16+00:00 https://destinypharma.com/2015/11/11/press-release-destiny-pharma-announces-qualified-infectious-disease-product-designation-granted-by-us-fda-for-novel-antibacterial-product-in-development-for-prevention-of-post-surg/ 2023-03-16T11:07:17+00:00 https://destinypharma.com/2015/10/22/health-minsters-committed-to-tackle-antimicrobial-resistance/ 2015-10-22T11:33:33+00:00 https://destinypharma.com/2015/10/06/beam-biotechs-from-europe-innovating-in-anti-microbial-resistance-alliance-release-first-position-paper-identifying-the-key-actions-required-to-reinvigorate-investment-and-rd-in-t/ 2015-10-06T11:34:32+00:00 https://destinypharma.com/2015/08/24/latest-figures-from-public-health-england-show-that-the-number-of-methicillin-sensitive-staphylococcus-aureus-mssa-blood-infection-bacteraemia-cases-continue-to-rise-in-the-uk/ 2015-08-24T11:36:58+00:00 https://destinypharma.com/2015/06/23/destiny-pharma-participates-in-the-launch-of-the-antibiotic-discovery-global-network/ 2015-06-23T11:37:40+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-to-attend-the-society-for-healthcare-epidemiology-of-america-shea-spring-2015-conference-science-guiding-prevention-in-orlando-florida/ 2015-05-08T11:38:15+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-invited-to-present-at-the-inaugural-pipeline-corner-event-to-be-held-during-the-25th-european-congress-of-clinical-microbiology-and-infectious-disease-eccmid-meeting/ 2015-03-16T11:38:58+00:00 https://destinypharma.com/2015/02/05/global-innovation-fund-recommended-to-be-set-up-to-support-new-ideas-to-combat-antimicrobial-resistance/ 2015-02-05T11:39:37+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-to-attend-drive-ab-driving-reinvestment-in-rd-and-the-responsible-use-of-antibiotics-meeting-in-london-on-february-9th/ 2015-01-08T11:40:17+00:00 https://destinypharma.com/2014/12/19/drug-resistant-superbugs-could-cost-up-to-100-trillion-and-cause-10-million-extra-deaths-a-year-by-2050/ 2014-12-19T11:40:49+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-invited-to-attend-the-first-event-of-the-review-on-antimicrobial-resistance-meeting-chaired-by-jim-oneill-and-hosted-by-the-wellcome-trust-on-the-11th-december-2014/ 2014-12-05T11:41:55+00:00 https://destinypharma.com/2014/11/17/antibiotic-awareness-day/ 2014-11-17T11:42:50+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-to-attend-idweek-in-philadelphia-pa/ 2014-10-01T11:43:39+00:00 https://destinypharma.com/2014/09/29/obama-administration-takes-actions-to-combat-antibiotic-resistant-bacteria/ 2014-09-29T11:44:20+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-to-attend-54th-interscience-conference-on-antimicrobial-agents-and-chemotherapy-icaac-conference-in-washington-dc/ 2014-09-04T11:45:16+00:00 https://destinypharma.com/2014/08/04/angel-cofund-join-uk-investors-in-2-8m-investment-for-superbug-killing-company/ 2014-08-04T11:45:56+00:00 https://destinypharma.com/2014/07/01/david-cameron-says-that-superbugs-can-cast-world-back-into-the-dark-ages-of-medicine/ 2014-07-01T11:46:59+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-to-attend-24th-european-congress-of-clinical-microbiology-and-infectious-disease-eccmid-conference-in-barcelona-spain/ 2014-04-01T11:47:53+00:00 https://destinypharma.com/2014/01/01/adapt-act-to-spur-antibiotic-development/ 2014-01-01T11:48:21+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-to-attend-32nd-annual-j-p-morgan-healthcare-conference-san-francisco/ 2013-12-20T11:49:44+00:00 https://destinypharma.com/news-and-media/events/6th-european-antibiotic-awareness-day/ 2013-11-18T11:50:15+00:00 https://destinypharma.com/news-and-media/events/destiny-pharma-to-attend-bioinfect-2013-conference/ 2013-11-07T11:50:50+00:00 https://destinypharma.com/2013/09/24/report-by-cdc-details-todays-drug-resistant-health-threats/ 2013-09-24T11:51:20+00:00 https://destinypharma.com/2013/09/19/uk-government-publish-strategy-to-combat-antimicrobial-resistance-between-2013-and-2018/ 2013-09-19T11:51:59+00:00 https://destinypharma.com/2013/05/20/press-release-part-2-of-niaid-funded-us-clinical-trial-of-anti-staphylococcal-nasal-gel-xf-73-begins-enrollment/ 2023-03-16T11:07:17+00:00 https://destinypharma.com/2013/03/01/chief-medical-officer-dame-sally-davies-publishes-annual-report-providing-a-comprehensive-overview-of-the-threat-of-antimicrobial-resistance-and-infectious-diseases/ 2013-03-01T11:53:22+00:00 https://destinypharma.com/2013/02/01/new-us-therapeutic-guidelines-on-antimicrobial-prophylaxis-published-which-recommend-that-all-higher-risk-surgeries-should-now-decolonise-all-patients-with-documented-colonisation-with/ 2013-02-01T11:54:01+00:00 https://destinypharma.com/2013/01/01/us-icu-infection-rate-cut-by-44-by-universal-bacterial-decolonisation-hospital-corporation-of-america-hca-icus-to-adopt-this-regimen-during-early-2013/ 2013-01-01T11:55:02+00:00 https://destinypharma.com/2013/01/01/chief-medical-officer-dame-sally-davies-says-that-antibiotic-resistant-diseases-pose-apocalyptic-threat-and-tells-mps-that-the-issue-should-be-added-to-the-uk-governments-national/ 2013-01-01T11:54:33+00:00 https://destinypharma.com/2012/10/17/national-institutes-of-health-launch-us-clinical-trial-of-xf-73-a-new-anti-staphylococcal-drug/ 2012-10-17T11:55:32+00:00 https://destinypharma.com/2012/07/01/generating-antibiotic-incentives-now-gain-act-passed-by-us-senate-on-26th-june-2012/ 2012-07-01T11:56:33+00:00 https://destinypharma.com/2012/03/26/press-release-ind-opens-for-anti-staphylococcal-drug-xf-73-and-niaid-funded-us-clinical-trial-begins/ 2023-03-16T11:07:17+00:00 https://destinypharma.com/2011/11/04/press-release-sir-nigel-rudd-to-lead-company-behind-mrsa-cure/ 2023-03-16T11:07:17+00:00